| Customization: | Available |
|---|---|
| CAS No.: | Customization, 388082-77-7 |
| Formula: | Customization, C181h291n55o51s 2 |
|
Still deciding? Get samples of US$ 400/kg
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
Introduction:
Lapatinib ditosylate is an innovative and potent medication that has gained significant attention in the field of oncology. With its excellent therapeutic properties, Lapatinib ditosylate has revolutionized the treatment of certain types of cancer, particularly breast cancer.
Lapatinib ditosylate works by inhibiting the activity of specific proteins known as tyrosine kinases, which are involved in the growth and spread of cancer cells. By targeting these proteins, Lapatinib ditosylate effectively disrupts the signaling pathways that promote cancer cell proliferation.
Function:
In terms of efficacy, studies have shown that Lapatinib ditosylate is highly effective in the treatment of HER2-positive breast cancer. This aggressive form of breast cancer is characterized by an overexpression of the HER2 protein, which promotes the rapid growth and division of cancer cells. Lapatinib ditosylate effectively inhibits the activity of the HER2 protein, leading to a significant reduction in tumor growth and improved patient outcomes.
Apart from breast cancer, Lapatinib ditosylate has also demonstrated promising results in the treatment of other types of solid tumors, including non-small cell lung cancer and gastric cancer. Its ability to target specific molecular pathways associated with cancer progression makes it a valuable option for patients who have not responded well to traditional chemotherapy.
Application:
The utility of Lapatinib ditosylate extends beyond its role as a standalone treatment. It is often used in combination with other chemotherapy agents or targeted therapies to enhance its effectiveness. This approach, known as combination therapy, allows for a more comprehensive and personalized treatment strategy for cancer patients.
1. Are you a manufacturer or trading company?
A: We are a manufacturer and welcome to visit our factory.
){kind=link}